Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Genome Editing/Genome Engineering market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Genome Editing/Genome Engineering market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Genome Editing/Genome Engineering market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Genome Editing/Genome Engineering products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Genome Editing/Genome Engineering products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Genome Editing/Genome Engineering market.
To learn more about this report
Increasing research and development spending on Genome Editing/Genome Engineering development has been the leading industry trend of Genome Editing/Genome Engineering market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Technology Outlook | CRISPR, TALEN, ZFN, Antisense, Other |
| By Application Outlook | Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery & Development, Other |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | Thermo Fisher Scientific, Merck KGaA, GenScript,Sangamo Therapeutics, Lonza,Editas Medicine, CRISPR Therapeutics AG, Tecan Life Sciences, Precision Biosciences, Agilent Technologies, PerkinElmer,Cellectis S.A, Intellia Therapeutics, Bluebird Bio |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
Table of Contents
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Genome Editing/Genome Engineering Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Product Type Market
2.1 World Product Type Market Performance and Trend
2.1.1 World Market Performance
2.1.2 Different Type of Market Performance
2.2 North America Product Type Market Performance and Trend
2.2.1 North America Market Performance
2.2.2 Different Type of Market Performance
2.3 Europe Product Type Market Performance and Trend
2.3.1 Europe Market Performance
2.3.2 Different Type of Market Performance
2.4 Asia-Pacific Product Type Market Performance and Trend
2.4.1 Asia-Pacific Market Performance
2.4.2 Different Type of Market Performance
2.5 South America Product Type Market Performance and Trend
2.5.1 South America Market Performance
2.5.2 Different Type of Market Performance
2.6 Middle East and Africa Product Type Market Performance and Trend
2.6.1 Middle East and Africa Market Performance
2.6.2 Different Type of Market Performance
3 Product Application Market
3.1 World Product Application Market Performance and Trend
3.1.1 World Market Performance
3.1.2 Different Applications of Market Trend
3.2 North America Product Application Market Performance and Trend
3.2.1 North America Market Performance
3.2.2 Different Applications of Market Trend
3.3 Europe Product Application Market Performance and Trend
3.3.1 Europe Market Performance
3.3.2 Different Applications of Market Trend
3.4 Asia-Pacific Product Application Market Performance and Trend
3.4.1 Asia-Pacific Market Performance
3.4.2 Different Applications of Market Trend
3.5 South America Product Application Market Performance and Trend
3.5.1 South America Market Performance
3.5.2 Different Applications of Market Trend
3.6 Middle East and Africa Product Application Market Performance and Trend
3.6.1 Middle East and Africa Market Performance
3.6.2 Different Applications of Market Trend
4 Manufacturers Profiles/Analysis
4.1 Thermo Fisher Scientific, Inc. (U.S.)
4.1.1 Thermo Fisher Scientific, Inc. (U.S.) Profiles
4.1.2 Thermo Fisher Scientific, Inc. (U.S.) Product Information
4.1.3 Thermo Fisher Scientific, Inc. (U.S.) Genome Editing/Genome Engineering Business Performance
4.1.4 Thermo Fisher Scientific, Inc. (U.S.) Genome Editing/Genome Engineering Business Development and Market Status
4.2 Merck KGAA (Germany)
4.2.1 Merck KGAA (Germany) Profiles
4.2.2 Merck KGAA (Germany) Product Information
4.2.3 Merck KGAA (Germany) Genome Editing/Genome Engineering Business Performance
4.2.4 Merck KGAA (Germany) Genome Editing/Genome Engineering Business Development and Market Status
4.3 Horizon Discovery Group Plc (U.K.)
4.3.1 Horizon Discovery Group Plc (U.K.) Profiles
4.3.2 Horizon Discovery Group Plc (U.K.) Product Information
4.3.3 Horizon Discovery Group Plc (U.K.) Genome Editing/Genome Engineering Business Performance
4.3.4 Horizon Discovery Group Plc (U.K.) Genome Editing/Genome Engineering Business Development and Market Status
4.4 Genscript Biotech Corporation (U.S.)
4.4.1 Genscript Biotech Corporation (U.S.) Profiles
4.4.2 Genscript Biotech Corporation (U.S.) Product Information
4.4.3 Genscript Biotech Corporation (U.S.) Genome Editing/Genome Engineering Business Performance
4.4.4 Genscript Biotech Corporation (U.S.) Genome Editing/Genome Engineering Business Development and Market Status
4.5 Sangamo Biosciences, Inc. (U.S.)
4.5.1 Sangamo Biosciences, Inc. (U.S.) Profiles
4.5.2 Sangamo Biosciences, Inc. (U.S.) Product Information
4.5.3 Sangamo Biosciences, Inc. (U.S.) Genome Editing/Genome Engineering Business Performance
4.5.4 Sangamo Biosciences, Inc. (U.S.) Genome Editing/Genome Engineering Business Development and Market Status
4.6 Integrated DNA Technologies, Inc (U.S.)
4.6.1 Integrated DNA Technologies, Inc (U.S.) Profiles
4.6.2 Integrated DNA Technologies, Inc (U.S.) Product Information
4.6.3 Integrated DNA Technologies, Inc (U.S.) Genome Editing/Genome Engineering Business Performance
4.6.4 Integrated DNA Technologies, Inc (U.S.) Genome Editing/Genome Engineering Business Development and Market Status
4.7 Lonza Group Ltd. (Switzerland)
4.7.1 Lonza Group Ltd. (Switzerland) Profiles
4.7.2 Lonza Group Ltd. (Switzerland) Product Information
4.7.3 Lonza Group Ltd. (Switzerland) Genome Editing/Genome Engineering Business Performance
4.7.4 Lonza Group Ltd. (Switzerland) Genome Editing/Genome Engineering Business Development and Market Status
4.8 New England Biolabs, Inc. (U.S.)
4.8.1 New England Biolabs, Inc. (U.S.) Profiles
4.8.2 New England Biolabs, Inc. (U.S.) Product Information
4.8.3 New England Biolabs, Inc. (U.S.) Genome Editing/Genome Engineering Business Performance
4.8.4 New England Biolabs, Inc. (U.S.) Genome Editing/Genome Engineering Business Development and Market Status
4.9 Origene Technologies, Inc. (U.S.)
4.9.1 Origene Technologies, Inc. (U.S.) Profiles
4.9.2 Origene Technologies, Inc. (U.S.) Product Information
4.9.3 Origene Technologies, Inc. (U.S.) Genome Editing/Genome Engineering Business Performance
4.9.4 Origene Technologies, Inc. (U.S.) Genome Editing/Genome Engineering Business Development and Market Status
4.10 Transposagen Biopharmaceuticals, Inc. (U.S.)
4.10.1 Transposagen Biopharmaceuticals, Inc. (U.S.) Profiles
4.10.2 Transposagen Biopharmaceuticals, Inc. (U.S.) Product Information
4.10.3 Transposagen Biopharmaceuticals, Inc. (U.S.) Genome Editing/Genome Engineering Business Performance
4.10.4 Transposagen Biopharmaceuticals, Inc. (U.S.) Genome Editing/Genome Engineering Business Development and Market Status
5 Market Performance for Manufacturers
5.1 Global Genome Editing/Genome Engineering Sales (K Units) and Market Share by Manufacturers 2017-2020
5.2 Global Genome Editing/Genome Engineering Revenue (M USD) and Market Share by Manufacturers 2017-2020
5.3 Global Genome Editing/Genome Engineering Price (USD/Unit) of Manufacturers 2017-2020
5.4 Global Genome Editing/Genome Engineering Gross Margin of Manufacturers 2017-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 North America Market Performance for Manufacturers
6.1.1 North America Genome Editing/Genome Engineering Sales (K Units) and Share of Manufacturers 2017-2020
6.1.2 North America Genome Editing/Genome Engineering Revenue (M USD) and Share of Manufacturers 2017-2020
6.1.3 North America Genome Editing/Genome Engineering Price (USD/Unit) of Manufacturers 2017-2020
6.1.4 North America Genome Editing/Genome Engineering Gross Margin of Manufacturers 2017-2020
6.1.5 Market Concentration
6.2 Europe Market Performance for Manufacturers
6.2.1 Europe Genome Editing/Genome Engineering Sales (K Units) and Share of Manufacturers 2017-2020
6.2.2 Europe Genome Editing/Genome Engineering Revenue (M USD) and Share of Manufacturers 2017-2020
6.2.3 Europe Genome Editing/Genome Engineering Price (USD/Unit) of Manufacturers 2017-2020
6.2.4 Europe Genome Editing/Genome Engineering Gross Margin of Manufacturers 2017-2020
6.2.5 Market Concentration
6.3 Asia-Pacific Market Performance for Manufacturers
6.3.1 Asia-Pacific Genome Editing/Genome Engineering Sales (K Units) and Share of Manufacturers 2017-2020
6.3.2 Asia-Pacific Genome Editing/Genome Engineering Revenue (M USD) and Share of Manufacturers 2017-2020
6.3.3 Asia-Pacific Genome Editing/Genome Engineering Price (USD/Unit) of Manufacturers 2017-2020
6.3.4 Asia-Pacific Genome Editing/Genome Engineering Gross Margin of Manufacturers 2017-2020
6.3.5 Market Concentration
6.4 South America Market Performance for Manufacturers
6.4.1 South America Genome Editing/Genome Engineering Sales (K Units) and Share of Manufacturers 2017-2020
6.4.2 South America Genome Editing/Genome Engineering Revenue (M USD) and Share of Manufacturers 2017-2020
6.4.3 South America Genome Editing/Genome Engineering Price (USD/Unit) of Manufacturers 2017-2020
6.4.4 South America Genome Editing/Genome Engineering Gross Margin of Manufacturers 2017-2020
6.4.5 Market Concentration
6.5 Middle East and Africa Market Performance for Manufacturers
6.5.1 Middle East and Africa Genome Editing/Genome Engineering Sales (K Units) and Share of Manufacturers 2017-2020
6.5.2 Middle East and Africa Genome Editing/Genome Engineering Revenue (M USD) and Share of Manufacturers 2017-2020
6.5.3 Middle East and Africa Genome Editing/Genome Engineering Price (USD/Unit) of Manufacturers 2017-2020
6.5.4 Middle East and Africa Genome Editing/Genome Engineering Gross Margin of Manufacturers 2017-2020
6.5.5 Market Concentration
7 World Market Performance Point
7.1 World Genome Editing/Genome Engineering Sales (K Units) and Share by Regions and Countries 2017-2020
7.1.1 World Genome Editing/Genome Engineering Sales (K Units) and Share by Regions 2017-2020
7.1.2 Regional Sales (K Units) and Share by Countries 2017-2020
7.1.2.1 Asia-Pacific Genome Editing/Genome Engineering Sales (K Units) and Share by Countries 2017-2020
7.1.2.2 North America Genome Editing/Genome Engineering Sales (K Units) and Share by Countries 2017-2020
7.1.2.3 Europe Genome Editing/Genome Engineering Sales (K Units) and Share by Countries 2017-2020
7.1.2.4 South America Genome Editing/Genome Engineering Sales (K Units) and Share by Countries 2017-2020
7.1.2.5 Middle East and Africa Genome Editing/Genome Engineering Sales (K Units) and Share by Countries 2017-2020
7.2 World Revenue (M USD) and Share by Regions and Countries 2017-2020
7.2.1 World Revenue (M USD) and Share by Regions 2017-2020
7.2.2 Regional Revenue (M USD) and Share by Countries 2017-2020
7.2.2.1 Asia-Pacific Genome Editing/Genome Engineering Revenue (M USD) and Share by Countries 2017-2020
7.2.2.2 North America Genome Editing/Genome Engineering Revenue (M USD) and Share by Countries 2017-2020
7.2.2.3 Europe Genome Editing/Genome Engineering Revenue (M USD) and Share by Countries 2017-2020
7.2.2.4 South America Genome Editing/Genome Engineering Revenue (M USD) and Share by Countries 2017-2020
7.2.2.5 Middle East and Africa Genome Editing/Genome Engineering Revenue (M USD) and Share by Countries 2017-2020
7.3 World Price (USD/Unit) by Regions and Countries 2017-2020
7.3.1 World Price (USD/Unit) by Regions 2017-2020
7.3.2 Regional Price (USD/Unit) by Countries 2017-2020
7.3.2.1 Asia-Pacific Genome Editing/Genome Engineering Price (USD/Unit) by Countries 2017-2020
7.3.2.2 North America Genome Editing/Genome Engineering Price (USD/Unit) by Countries 2017-2020
7.3.2.3 Europe Genome Editing/Genome Engineering Price (USD/Unit) by Countries 2017-2020
7.3.2.4 South America Genome Editing/Genome Engineering Price (USD/Unit) by Countries 2017-2020
7.3.2.5 Middle East and Africa Genome Editing/Genome Engineering Price (USD/Unit) by Countries 2017-2020
7.4 World Gross Margin by Regions and Countries 2017-2020
7.4.1 World Gross Margin by Regions 2017-2020
7.4.2 Regional Gross Margin and Share by Countries 2017-2020
7.4.2.1 Asia-Pacific Genome Editing/Genome Engineering Gross Margin and Share by Countries 2017-2020
7.4.2.2 North America Genome Editing/Genome Engineering Gross Margin and Share by Countries 2017-2020
7.4.2.3 Europe Genome Editing/Genome Engineering Gross Margin and Share by Countries 2017-2020
7.4.2.4 South America Genome Editing/Genome Engineering Gross Margin and Share by Countries 2017-2020
7.4.2.5 Middle East and Africa Genome Editing/Genome Engineering Gross Margin and Share by Countries 2017-2020
8 Development Trend for Regions and Countries (Sales Point)
8.1 World Genome Editing/Genome Engineering Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.2 Asia-Pacific Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.2.1 China Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.2.2 Japan Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.2.3 Korea Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.2.4 India Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.2.5 Southeast Asia Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.3 North America Genome Editing/Genome Engineering Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.3.1 United States Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.3.2 Canada Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.3.3 Mexico Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.4 Europe Genome Editing/Genome Engineering Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.4.1 Germany Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.4.2 UK Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.4.3 France Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.4.4 Russia Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.4.5 Italy Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.5 South America Genome Editing/Genome Engineering Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.5.1 Brazil Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.5.2 Argentina Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.5.3 Columbia Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.6 Middle East and Africa Genome Editing/Genome Engineering Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.6.1 Saudi Arabia Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.6.2 UAE Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.6.3 Egypt Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.6.4 Nigeria Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
8.6.5 South Africa Sales (K Units), Revenue (M USD) and Growth Rate 2017-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 Cell Line Engineering Industry
11.2 Animal Genetic Engineering Industry
11.3 Plant Genetic Engineering Industry
11.4 Other Applications Industry
12 Market Forecast 2021-2028
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2028
12.1.1 Global Genome Editing/Genome Engineering Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2028
12.1.2 Global Genome Editing/Genome Engineering Sales (K Units) and Growth Rate 2021-2028
12.1.3 Asia-Pacific Genome Editing/Genome Engineering Sales (K Units), Revenue (M USD) and Growth Rate 2021-2028
12.1.4 North America Genome Editing/Genome Engineering Sales (K Units), Revenue (M USD) and Growth Rate 2021-2028
12.1.5 Europe Genome Editing/Genome Engineering Sales (K Units), Revenue (M USD) and Growth Rate 2021-2028
12.1.6 South America Genome Editing/Genome Engineering Sales (K Units), Revenue (M USD) and Growth Rate 2021-2028
12.1.7 Middle East and Africa Genome Editing/Genome Engineering Sales (K Units), Revenue (M USD) and Growth Rate 2021-2028
12.2 World Genome Editing/Genome Engineering Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2028
12.2.1 Overall Market Performance
12.2.2 CRISPR Sales (K Units), Revenue (M USD) and Growth Rate 2021-2028
12.2.3 TALEN Sales (K Units), Revenue (M USD) and Growth Rate 2021-2028
12.2.4 ZFN Sales (K Units), Revenue (M USD) and Growth Rate 2021-2028
12.2.5 Antisense Sales (K Units), Revenue (M USD) and Growth Rate 2021-2028
12.2.6 Other Technologies Sales (K Units), Revenue (M USD) and Growth Rate 2021-2028
12.3 World Genome Editing/Genome Engineering Market Forecast by Application 2021-2028
12.3.1 Overall Market Performance
12.3.2 Cell Line Engineering Sales and and Growth Rate 2021-2028
12.3.3 Animal Genetic Engineering Sales and and Growth Rate 2021-2028
12.3.4 Plant Genetic Engineering Sales and and Growth Rate 2021-2028
12.3.5 Other Applications Sales and and Growth Rate 2021-2028
12.4 Price (USD/Unit) and Gross Profit Forecast
12.4.1 Global Genome Editing/Genome Engineering Price (USD/Unit) Trend 2021-2028
12.4.2 Global Genome Editing/Genome Engineering Gross Profit Trend 2021-2028
13 Conclusion
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
A faster and efficient way to cater to the needs with continuous iteration
Focus on Data Accuracy & Reliability
75+ Clients in Fortune 500
All your transactions are secured end-to-end, ensuring a satisfactory purchase
Ensure the best and affordable pricing
